Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2003
11/27/2003CA2486141A1 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
11/27/2003CA2486112A1 Allergen mutants
11/27/2003CA2486106A1 Compounds and methods for inhibiting selectin-mediated function
11/27/2003CA2486061A1 Using a selective inos inhibitor for the treatment of respiratory diseases and conditions
11/27/2003CA2485933A1 5-ethylimidarotriazones
11/27/2003CA2485896A1 Pyridazin-3(2h)-one derivatives as pde4 inhibitors
11/27/2003CA2485453A1 Polypeptide antigen inducing hiv neutralizing antibodies
11/27/2003CA2484702A1 Substituted 4-aryl-4h-pyrrolo[2,3-h]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/27/2003CA2484646A1 Hormone replacement therapy using a combination of conjugated estrogens and trimegestone
11/27/2003CA2484631A1 Phenyl substituted imidazopyridines and phenyl substituted benzimidazoles
11/27/2003CA2483770A1 Trimegestone and estrogens for treating post menopausal disorders
11/27/2003CA2483712A1 Use of modified novirhabdoviruses to obtain vaccines
11/27/2003CA2483190A1 External preparation for allergic diseases
11/27/2003CA2482756A1 Indole derivatives and the use thereof as cb<sb>2</sb> receptor ligands
11/27/2003CA2482746A1 Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders
11/26/2003EP1365024A1 Traf3-binding b cell-specific receptor
11/26/2003EP1364953A1 Triazoloquinazoline and pyrazolotriazolopyrimidine derivatives, medicinal compositions, adenosine a3 receptor affinity agents, ocular tension lowering agents, preparations for preventing and treating glaucoma and method of lowering ocular tension
11/26/2003EP1364952A1 Bicyclic nitrogenous fused-ring compound
11/26/2003EP1364949A1 Jnk inhibitor
11/26/2003EP1364943A1 Novel cystine derivatives and inhibitors for the activation of inflammatory factors
11/26/2003EP1364653A1 Casoase 3 inhibitors
11/26/2003EP1364586A1 Probiotics and oral tolerance
11/26/2003EP1364023A2 Method of diagnosing and treating cartilage disorders
11/26/2003EP1364017A2 Inflammation related g-protein coupled receptor
11/26/2003EP1364014A2 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
11/26/2003EP1364010A2 Immunomodulatory polynucleotides and methods of using the same
11/26/2003EP1363994A2 Thymic epithelial progenitor cells and uses thereof
11/26/2003EP1363993A2 METHODS OF TREATING INFLAMMATORY AND IMMUNE DISEASES USING INHIBITORS OF I$g(k)B KINASE (IKK)
11/26/2003EP1363950A2 Bispecific monoclonal antibodies to il-12 and il-18 receptors
11/26/2003EP1363943A2 Interferon regulatory factor-1/human estrogen receptor fusion protein and its use for treating carcinomas
11/26/2003EP1363938A2 Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
11/26/2003EP1363937A2 Immunomodulating agents from parasitic worms and method for isolation thereof
11/26/2003EP1363910A2 Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
11/26/2003EP1363906A2 Heterocyclic inhibitors of erk2 and uses thereof
11/26/2003EP1363904A1 Pyrazoles as tgf inhibitors
11/26/2003EP1363902A1 Chemical compounds
11/26/2003EP1363900A1 Isoindole-imide compounds as tnf-inhibitors
11/26/2003EP1363898A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/26/2003EP1363897A2 Antagonists of mcp-1 function and methods of use thereof
11/26/2003EP1363881A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
11/26/2003EP1363876A1 Glucocorticoid receptor modulators
11/26/2003EP1363875A2 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity
11/26/2003EP1363874A2 Tryptase inhibitors
11/26/2003EP1363705A1 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
11/26/2003EP1363703A2 Disease prevention by reactivation of the thymus
11/26/2003EP1363702A1 Methods of inhibiting kinases
11/26/2003EP1363670A1 Polynucleotide formulation for enhanced intracellular transfer
11/26/2003EP1363666A1 Methods for treating disease states comprising administration of low levels of antibodies
11/26/2003EP1363665A2 Vaccine
11/26/2003EP1363664A2 Synthetic vaccine agents
11/26/2003EP1363663A2 Nucleic acid mucosal immunization
11/26/2003EP1363642A2 Administration of an anti-endotoxin drug by bolus or intermittent intravenous infusion
11/26/2003EP1363640A2 Nucleic acid derivatives
11/26/2003EP1363635A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
11/26/2003EP1363632A1 Receptor selective cannabimimetic aminoalkylindoles
11/26/2003EP1363631A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/26/2003EP1363629A1 Kappa opioid receptor ligands
11/26/2003EP1363613A2 Use of rhein for preparing a medicine for treating a high rate of il-1
11/26/2003EP1363594A1 Cosmetic formulations containing flavonoid derivatives
11/26/2003EP1363581A2 Pyrrolo(2,3-d)pyrimidine nucleoside analogs
11/26/2003EP1268487B1 Tricyclic protein kinase inhibitors
11/26/2003EP1248608B1 Diacerein for use in treating psoriasis
11/26/2003EP0912601B1 Suppression of immune response via inhibition of cathepsin s
11/26/2003EP0814813B1 Use of penciclovir for the treatment of human herpes-virus-8
11/26/2003EP0765326B1 Benzoylecgonine, ecgonine and ecgonidine derivatives
11/26/2003CN1458929A Chemokine receptor binding heterocyclic compounds
11/26/2003CN1458922A Urea derivative and adhesive-molecule inhibitor containing same as ctive ingredient
11/26/2003CN1458846A Synthetic erythropoiesis stimulating protein
11/26/2003CN1458844A Method of using diketopiperazines and composition containing them
11/26/2003CN1458282A Preparing method for producing high level immunity induced by nucleic molecule and using method
11/26/2003CN1457882A Recombined human interleukin-2 and its derivative injection and preparing method
11/26/2003CN1457880A Polyresistin dripping pill and its preparing method for immunodeficiency
11/26/2003CN1457847A Composition of full scorpion powder and centipede powder and its preparing method
11/26/2003CN1457846A Lindera root essence and its producing method
11/26/2003CN1457824A Chinese medicinal pill for reinforcing kidney and strengthening yang, warming and recuperating Qi and blood, and improving crganism immunity
11/26/2003CN1457809A Dandelion preparation and preparing method
11/26/2003CN1457808A Iron scale dendrobium compound preposition and preparation and use
11/26/2003CN1457802A Snake powder and leech powder composition and preparing method
11/26/2003CN1457781A Cetirizing hydrochloride cataplasm preparation
11/26/2003CN1457765A Cetirizine hydrochloride gel
11/26/2003CN1128800C Pyrolo [2,3-d] pyrimidine compounds and its composition and use
11/26/2003CN1128798C Pharmaceutically active tricyclic amines
11/26/2003CN1128789C Benzocycloheptathiophene compounds
11/25/2003US6653508 Use treating various medical conditions, including pain
11/25/2003US6653476 Thienopyridine derivatives, their production and use
11/25/2003US6653448 Wnt-7B-like polypeptides and nucleic acids encoding same
11/25/2003US6653347 For therapy
11/25/2003US6653326 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof
11/25/2003US6653313 1,4-dihydropyridine compounds as bradykinin antagonists
11/25/2003US6653312 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
11/25/2003US6653310 For therapy of disease states mediated by the chemokine, Interleukin-8 (IL-8)
11/25/2003US6653301 For therapy of cancer, diabetes and Alzheimer's disease
11/25/2003US6653300 Pyrazole compounds useful as protein kinase inhibitors
11/25/2003US6653296 Antiretroviral enantiomeric nucleotide analogs
11/25/2003US6653292 Stimulating Th1 pattern of immune activation, cytokine production, NK lytic activity and B cell proliferation; modulating with nucleic acid sequences containing unmethylated CpG dinucleotides
11/25/2003US6653285 Polypeptide inhibitors and enhancers of glycosaminoglycans such as hyaluronic acid, chondroitin sulfate, dermatan sulfate, heparin, keratan sulfate, chitin and chitosans; antiinflammatory and anticarcinogenic agents; infections
11/25/2003US6653133 Antisense modulation of Fas mediated signaling
11/25/2003US6653125 Synthetic hepatitis C genes
11/25/2003US6652858 Administering an OX-2 protein or a nucleic acid encoding it to preventing graft rejection, fetal loss, autoimmune disease, and allergies; immunosuppressants; gene therapy
11/25/2003US6652856 Method for the treatment of fibrosis
1 ... 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 ... 1172